Literature DB >> 2465496

Pathological changes in olfactory neurons in patients with Alzheimer's disease.

B R Talamo1, R Rudel, K S Kosik, V M Lee, S Neff, L Adelman, J S Kauer.   

Abstract

Alzheimer's disease is a central nervous system disorder characterized by the presence of neurofibrillary tangles, neuritic plaques and dystrophic neurites in susceptible areas of the brain. Investigation of the mechanism and development of the disease has been hampered by the lack of an animal model and the inaccessibility of neural tissue during the illness. Deficits in odour detection and discrimination are among the signs of Alzheimer's and previous anatomical studies suggest that olfactory pathways may be involved early in the illness. Neurons in the olfactory epithelium, which are of central origin, are relatively accessible for biopsy and could be used as a source of living nerve cells for the study of Alzheimer's disease if they can be shown to have characteristics of this disease. As these neurons have the unusual property of arising from stem cells throughout the life of the organism, they are good candidates for the development of cell cultures or cell lines which may express the disorder from living patients. We report here that nasal epithelium tissue taken at autopsy shows unique pathological changes in morphology, distribution and immunoreactivity of neuronal structures in patients with Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2465496     DOI: 10.1038/337736a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  58 in total

1.  An olfactory sensory neuron line, odora, properly targets olfactory proteins and responds to odorants.

Authors:  J R Murrell; D D Hunter
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

2.  Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase.

Authors:  G Jedlitschky; A J Cassidy; M Sales; N Pratt; B Burchell
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

3.  Activation of Glycogen Synthase Kinase-3 Mediates the Olfactory Deficit-Induced Hippocampal Impairments.

Authors:  Juan Hu; He-Zhou Huang; Xiang Wang; Ao-Ji Xie; Xiong Wang; Dan Liu; Jian-Zhi Wang; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2014-11-05       Impact factor: 5.590

4.  Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features.

Authors:  Yang Li; Yaping Wang; Guorong Wu; Feng Shi; Luping Zhou; Weili Lin; Dinggang Shen
Journal:  Neurobiol Aging       Date:  2011-01-26       Impact factor: 4.673

5.  Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease.

Authors:  Steven E Arnold; Edward B Lee; Paul J Moberg; Lauren Stutzbach; Hala Kazi; Li-Ying Han; Virginia M Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

6.  In vivo olfactory model of APP-induced neurodegeneration reveals a reversible cell-autonomous function.

Authors:  Ning Cheng; Huaibin Cai; Leonardo Belluscio
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

7.  Disruption of odour quality coding in piriform cortex mediates olfactory deficits in Alzheimer's disease.

Authors:  Wen Li; James D Howard; Jay A Gottfried
Journal:  Brain       Date:  2010-08-19       Impact factor: 13.501

8.  Hypothesis: microtubules, a key to Alzheimer disease.

Authors:  S S Matsuyama; L F Jarvik
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

Review 9.  Review and hypothesis: Alzheimer disease and Down syndrome--chromosome 21 nondisjunction may underlie both disorders.

Authors:  H Potter
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

10.  Neurofilament profile in olfactory mucosa of patients with a clinical diagnosis of Alzheimer's disease.

Authors:  S Kaakkola; J Palo; H Malmberg; R Sulkava; I Virtanen
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.